A Multicenter Compassionate Use Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C

Hepatitis C Articles (HCV)


A Multicenter Compassionate Use Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C - Europe

	Verified April 2014 by Bristol-Myers Squibb ......https://clinicaltrials.gov/ct2/show/NCT02097966?term=daclatasvir+sofosbuvir&rank=4 NHS England agrees funding for life-saving hepatitis C drug(s) sofosbuvir, daclatasvir - (06/09/14) Scotland.....Hepatitis C drug is approved.... - (06/11/14)

View Older Articles

Back to Top

www.natap.org